Oil's rise above $100 per barrel has unleashed fears of a more severe economic impact from the war in the Middle East.

Stocks have recouped their overnight losses, but while oil is full of sound and fury, the decline in equities is likely to be ...

Shares of 3D printing company 3D Systems (NYSE:DDD) jumped 11.1% in the morning session after the company reported ...

FuelCell Energy (NASDAQ: FCEL) stock tumbled 7.2% through 12:30 p.m. ET Monday after reporting mixed earnings for its fiscal ...

Billionaire Ray Dalio feels the debate between gold and bitcoin has a clear winner. In his opinion, the precious metal ...

Netflix’s (NASDAQ:NFLX) ambitious push to acquire key assets from Warner Bros. Discovery (NASDAQ:WBD) in late 2025 quickly ...

Barclays reduced its price target on Oracle shares to $230 from $310 while maintaining an Overweight rating. Analyst Raimo Lenschow said the company's fiscal third-quarter results are expected to show ...

TAMPA, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN) marked the opening of its International Headquarters on March 5 at the University of South Florida (USF) Institute for ...

Legalweek, New York, March 09, 2026 (GLOBE NEWSWIRE) -- Legal AI is entering a new phase. The first wave proved that generative AI can draft, summarize, and brainstorm at speed. The next wave is ...

Oil is back above $110 a barrel. And this 156-year-old Dividend Aristocrat is sitting in an enviable position. When crude prices spike, not every oil company benefits equally. Some are more exposed to ...

Stocks fell and oil prices hit their highest level since 2022 traded above $100 per barrel as investors Monday grappled with a potential energy crisis caused by the war with Iran.

Analysts are encouraged by azetukalner’s differentiated MoA and efficacy in epilepsy, as well as the lack of titration needed when prescribing the drug.